Subscribe To
Btc bears to retarget sub-$26,000 with more sec moves likely
It is a quiet day ahead for BTC. With no US economic indicators or Fed chatter to consider, US lawmaker and regulatory activity will be focal points. ...
June 9, 2023, 12:29 am
Usd/jpy bears target sub-139 on hotter q1 gdp numbers
GDP numbers from Japan weighed on the USD/JPY this morning. The better-than-expected Q1 numbers should draw in attention of the BoJ. The post USD/JPY ...
June 8, 2023, 3:05 am
Arbutus to present ab-729 and ab-836 data at easl congress 2023
WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveragin...
June 7, 2023, 6:01 am
Eur/usd bears to target sub-$1.0650 on german industrial production
It is another busy session for the EUR/USD. However, with no Fed chatter to consider, the ECB and German economic indicators will be focal points. The...
June 7, 2023, 3:59 am
Arbutus to present ab-729 and ab-836 data at easl congress 2023
WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging...
June 7, 2023, 2:01 am
target stock is finally cheap enough to buy
Target's growth has stalled amid a tough economic environment, and profits are diving. The stock has been pummeled, bringing the valuation down to a r...
June 6, 2023, 6:50 am
Keybanc just turned dovish on target stock: find out why
Target Corp (NYSE: TGT) has lost nearly 20% in less than a month but a KeyBanc analyst still doesn't find this stock as attractive. What could hurt th...
June 5, 2023, 5:41 pm
target shares hit with another downgrade
target shares were downgraded for the second time in less than a week as headwinds mount for the retail...
June 5, 2023, 1:05 pm
Dollar general, target stocks downgraded amid fears of a consumer slowdown
Yahoo Finance Live's Julie Hyman and Brad Smith report on Dollar General and target shares trading lowe...
June 5, 2023, 11:17 am
5 stocks with recent price strength from a mixed may
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are...
June 5, 2023, 9:10 am
Walmart's pride merchandising unchanged as target sees backlash over new items
Walmart's Chief Merchandising Officer Latriece Watkins said the company's merchandise assortment caters to all different groups all year round and tha...
June 2, 2023, 11:30 am
Keysight (keys) augments automotive testing portfolio bouquet
Keysight's (KEYS) E8717A Lidar target simulator complements its existing automotive testing portfolio a...
June 2, 2023, 8:38 am
Btc bears to target sub-$27,000 on debt ceiling relief
It is a quiet day for BTC, with the US stats, the Fed, and debt ceiling news in focus. The stats will need to beat expectations to test Fed bets for J...
June 2, 2023, 12:42 am
Down 10% to 30%, these stocks are essential bear market buys
Earnings at Etsy and target soared earlier in the pandemic. In recent quarters, business has been tough...
June 1, 2023, 5:30 am
Arbutus to present at jefferies healthcare conference
WARMINSTER, Pa., May 31, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage...
May 31, 2023, 11:30 am
Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...
May 31, 2023, 3:00 am
Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...
May 31, 2023, 3:00 am
Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...
May 31, 2023, 3:00 am
Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...
May 31, 2023, 3:00 am
Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...
May 31, 2023, 3:00 am